Mostly True
A claim that artificial intelligence systems were able to access non-public clinical result documents held by South Korea's Ministry of Food and Drug Safety has been assessed as largely consistent with available information, though a definitive confirmation was not possible because the underlying material rests on a single source.
The assessment relied on 12 primary sources reviewed for the claim, which centers on whether AI had access to the ministry's undisclosed clinical result papers. The core supporting material includes screenshots referenced from a KBS report and imagery from the ministry's drug information portal, along with a social media post by a lawmaker's office that could not be fully opened due to login restrictions.
Because the key evidence stems from a single reporting pillar and the full post could not be directly examined, the claim could not be established as fully factual. No independent confirmation from other media outlets was available in the reviewed material.
The exact scope of the alleged exposure — including which clinical documents were involved, how AI systems accessed them, and whether any data protection rules were breached — remains unconfirmed in the available evidence. Direct verification of the lawmaker's office press material would be required to settle those points.
The available evidence supports the core of the claim, but the lack of independent corroboration and inaccessible source material leave room for doubt, making the overall assessment Mostly True.